Dave Coulier, non-Hodgkin lymphoma

French biotech Innate Pharma is recruiting natural-born killers to target B cell non-Hodgkin lymphoma (B-NHL). | French ...
“(My doctors) said, ‘Hey, we wish we had better news, but you have non-Hodgkin lymphoma, B-cell lymphoma,’” Coulier recalls. “It was a shock.” Despite his cancer diagnosis, Coulier is ...